Skip to main content
. 2007 Oct 18;15(1):186–192. doi: 10.1245/s10434-007-9535-0

FIG. 3.

FIG. 3.

Overall survival of re-explored, unresectable patients and 256 unresectable patients. The survival of a control cohort of 256 PDAC patients who were unresectable (n = 265) was compared with re-explored, unresectable patients (n = 15; red), revealing no differences in survival (P = 0.45).